Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Gene therapy for pancreatitis pain

Gene Therapy volume 16, pages 483–492 (2009)Cite this article

Abstract

Pancreatic cancer and chronic pancreatitis are clinical syndromes associated with severe pain that is difficult to manage. Thus, seeking additional pain reduction therapies is warranted. Excessive alcohol consumption over an extended period of time is the primary causal agent in pancreatitis. The efficacy of a replication defective Herpes (HSV-1, DPE) viral vector construct encoding the human preproenkephalin gene (HSV-Enk), used as a molecular therapy for alleviation of pancreatitis pain, is reviewed here. The characteristics of the gene therapy treatment for inflammation and pain-related behavior in two alcoholic pancreatitis animal models is described. Significant analgesia and protection of pancreatic tissue was provided for the duration of the transgene expression (∼4–6 weeks). These studies establish a basis for use of HSV-based gene therapy for chronic visceral pain. Targeted enkephalin gene therapy approaches are providing clear promise for pain control. As innovative means of significantly reducing pancreatic inflammation and preserving tissue architecture, they may extend their clinical usefulness for pancreatitis and pancreatic cancer pain patients.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Okuyama M, Shibata T, Morita T, Kitada M, Tukahara Y, Fukushima Y et al. A comparison of intraoperative celiac plexus block with pharmacological therapy as a treatment for pain of unresectable pancreatic cancer. J Hepatobiliary Pancreat Surg 2002; 9: 372–375.

    Article  PubMed  Google Scholar 

  2. Vranken JH, Zuurmond WW, Van Kemenade FJ, Dzoljic M . Neurohistopathologic findings after a neurolytic celiac plexus block with alcohol in patients with pancreatic cancer pain. Acta Anaesthesiol Scand 2002; 46: 827–830.

    Article  CAS  PubMed  Google Scholar 

  3. Schmulewitz N, Hawes R . EUS-guided celiac plexus neurolysis—technique and indication. Endoscopy 2003; 35: S49–S53. Review.

    Article  CAS  PubMed  Google Scholar 

  4. Klapman JB, Chang KJ . Endoscopic ultrasound-guided fine-needle injection. Gastrointest Endosc Clin N Am 2005; 15: 169–177. Review.

    Article  PubMed  Google Scholar 

  5. Bonica JJ . The Management of Pain. Lea & Febiger: Philadelphia, PA, 1990, pp 1222–1225.

    Google Scholar 

  6. Detakats G, Walter LE . The treatment of pancreatic pain by splanchnic nerve section. Surg Gynecol Obstet 1947; 85: 742–746.

    CAS  Google Scholar 

  7. Gorbitz C, Leavens ME . Alcohol block of the celiac plexus for control of upper abdominal pain caused by cancer and pancreatitis. Technical note. J Neurosurg 1971; 34: 575–579.

    Article  CAS  PubMed  Google Scholar 

  8. Hurwitz A, Gurwittz J . Relief of pain of chronic relapsing pancreatitis by unilateral sympathectomy. Arch Surg 1950; 61: 372–378.

    Article  Google Scholar 

  9. Rack FJ, Elkins CW . Experiences with vagotomy and sympathectomy in the treatment of chronic recurrent pancreatitis. Arch Surg 1950; 61: 943.

    Article  Google Scholar 

  10. Ray BS, Neill CL . Abdominal visceral sensation in man. Ann Surg 1947; 126: 709–724.

    Article  PubMed Central  PubMed  Google Scholar 

  11. Stone HH, Chauvin EJ . Pancreatic denervation for pain relief in chronic alcohol associated pancreatitis. Br J Surg 1990; 77: 303–305.

    Article  CAS  PubMed  Google Scholar 

  12. Chan VW . Chronic diarrhea: an uncommon side effect of celiac plexus block. Anesth Analg 1996; 82: 205–207.

    CAS  PubMed  Google Scholar 

  13. Kulke MH . Metastatic pancreatic cancer. Curr Treat Options Oncol 2002; 3: 449–457. Review.

    Article  PubMed  Google Scholar 

  14. Schmidt J, Compton CC, Rattner DW, Lewandrowski K, Warshaw AL . Late histopathologic changes and healing in an improved rodent model of acute necrotizing pancreatitis. Digestion 1995; 56: 246–252.

    Article  CAS  PubMed  Google Scholar 

  15. Merkord J, Jonas L, Weber H, Kroning G, Nizze H, Hennighausen G . Acute interstitial pancreatitis in rats induced by dibutyltin dichloride (DBTC): pathogenesis and natural course of lesions. Pancreas 1997; 15: 392–401.

    Article  CAS  PubMed  Google Scholar 

  16. Sparmann G, Merkord J, Jaschke A, Nizze H, Jonas L, Lohr M et al. Pancreatic fibrosis in experimental pancreatitis induced by dibutyltin dichloride. Gastroenterology 1997; 112: 1664–1672.

    Article  CAS  PubMed  Google Scholar 

  17. Schmidt J, Rattner DW, Lewandrowski K, Compton CC, Mandavilli U, Knoefel WT et al. A better model of acute pancreatitis for evaluating therapy. Ann Surg 1992; 215: 44–56.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  18. Cooperman AM . Chronic pancreatitis. Surg Clin North Am 1981; 61: 71–83.

    Article  CAS  PubMed  Google Scholar 

  19. Kloppel G . Pathology of chronic pancreatitis and pancreatic pain. Acta Chir Scand 1990; 156: 261–265.

    CAS  PubMed  Google Scholar 

  20. Lu Y, McNearney TA, Yeomans DC, Wilson SP, Westlund KN . Treatment of pancreas with enkephalin encoding HSV-1 recombinant vector reduces inflammatory damage and behavioral sequelae in a rat pancreatitis model. Mol Ther 2007; 15: 1812–1819.

    Article  CAS  PubMed  Google Scholar 

  21. Yang H, McNearney TA, Chu R, Lu Y, Ren Y, Yeomans DC et al. Enkephalin-encoding herpes simplex virus-1 decreases inflammation and hotplate sensitivity in a chronic pancreatitis model. Mol Pain 2008; 4: 8.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  22. Antunes bras J, Becker C, Bourgoin S, Lombard M, Cesselin F, Hamon M et al. Met-enkephalin is preferentially transported into the peripheral processes of primary afferents fibres in both control and HSV-1 driven proenkephalin A overexpressing rats. Neurosci 2001; 103: 1073–1083.

    Article  CAS  Google Scholar 

  23. Rohde DS, McKay WR, Chang DS, Abbadie C, Basbaum AI . The contribution of supraspinal, peripheral and intrinsic spinal circuits to the pattern and magnitude of Fos-like immunoreactivity in the lumbar spinal cord of the rat withdrawing from morphine. Neurosci 1997; 80: 599–612.

    Article  CAS  Google Scholar 

  24. Yokoyama H, Saski K, Franks ME, Goins WF, Goss JR, deGroat WC et al. Gene therapy for bladder overactivity and nociception with herpes simplex virus vectors expressing preproenkephalin. Human Gene Ther 2009; 20: 63–71.

    Article  CAS  Google Scholar 

  25. Goss JR, Mata M, Goins WF, Wu HH, Glorioso JC, Fink DJ . Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal root ganglion. Gene Therapy 2001; 8: 551–556.

    Article  CAS  PubMed  Google Scholar 

  26. Hao S, Mata M, Goins W, Glorioso JC, Fink DJ . Transgene-mediated enkephalin release enhances the effect of morphine and evades tolerance to produce a sustained antiallodynic effect in neuropathic pain. Pain 2003; 102: 135–142.

    Article  CAS  PubMed  Google Scholar 

  27. Kim S, Zhou M . Biphasic modulation of behavioral nociceptive responses by morphine in adult mice after amputation. Acta Physiol Sinica 2004; 54: 436–443.

    Google Scholar 

  28. Buscher HC, Wilder-Smith OH, van Goor H . Chronic pancreatitis patients show hyperalgesia of central origin: a pilot study. Eur J Pain 2006; 10: 363–370.

    Article  PubMed  Google Scholar 

  29. Buscher HC, van Goor H, Wilder-Smith OH . Effect of thoracoscopic splanchnic denervation on pain processing in chronic pancreatitis patients. Eur J Pain 2007; 11: 437–443.

    Article  CAS  PubMed  Google Scholar 

  30. Gavériaux C, Peluso J, Simonin F, Laforet J, Kieffer B . Identification of kappa- and delta-opioid receptor transcripts in immune cells. FEBS Lett 1995; 369: 272–276.

    Article  PubMed  Google Scholar 

  31. Cadet P, Bilfinger TV, Fimiani C, Peter D, Stefano GB . Human vascular and cardiac endothelia express mu opiate receptor transcripts. Endothelium 2000; 7: 185–191.

    Article  CAS  PubMed  Google Scholar 

  32. Saeed RW, Stefano DB, Murga JD, Short TW, Qi F, Bilfinger TV et al. Expression of functional delta opioid receptors in vascular smooth muscle. Int J Mol Med 2000; 6: 673–677.

    CAS  PubMed  Google Scholar 

  33. Bigliardi PL, Buchner S, Rufli T, Bigliardi-Qi M . Specific stimulation of migration of human keratinocytes by mu-opiate receptor agonists. J Recept Signal Transduct Res 2002; 22: 191–199.

    Article  CAS  PubMed  Google Scholar 

  34. Morgan EL . Regulation of human B lymphocyte activation by opioid peptide hormones inhibition of IgG production by opioids receptor class (u-, k-, and d-) selective agonists. J Neuroimmuno 1996; 65: 21–30.

    Article  CAS  Google Scholar 

  35. Rahim RT, Meissler JJJ, Cowan A, Rogers TJ, Geller EB, Gaughan J et al. Administration of mu-, kappa- or delta2-receptor agonists via osmotic minipumps suppresses murine splenic antibody responses. Int Immunopharmacol 2001; 1: 2001–2009.

    Article  CAS  PubMed  Google Scholar 

  36. Grimm MC, Ben-Baruch A, Taub DD, Howard OMZ, Wang JM, Oppenheimer JJ . Opiate inhibition of chemokines-induced chemotaxis. Ann NY Acad Sci 1998; 840: 9–20.

    Article  CAS  PubMed  Google Scholar 

  37. Rees H, Sluka KA, Westlund KN, Willis WD . Do dorsal root reflexes augment peripheral inflammation? Neuroreport 1994; 5: 821–824.

    Article  CAS  PubMed  Google Scholar 

  38. Ren K, Dubner R . Central nervous system plasticity and persistent pain. J Orofac Pain 1999; 13: 155–163.

    CAS  PubMed  Google Scholar 

  39. Sluka KA, Willis WD, Westlund KN . Joint inflammation and hyperalgesia are reduced by spinal bicuculline. Neuroreport 1993; 5: 109–112.

    Article  CAS  PubMed  Google Scholar 

  40. Sluka KA, Jordan HH, Westlund KN . Reduction in joint swelling and hyperalgesia following post-treatment with a non-NMDA glutamate receptor antagonist. Pain 1994; 59: 95–100.

    Article  CAS  PubMed  Google Scholar 

  41. Sluka KA, Westlund KN . Centrally administered non-NMDA but not NMDA receptor antagonists block peripheral knee joint inflammation. Pain 1993; 55: 217–225.

    Article  CAS  PubMed  Google Scholar 

  42. Sorkin LS, Moore J, Boyle DL, Yang L, Firestein GS . Regulation of peripheral inflammation by spinal adenosine: role of somatic afferent fibers. Exp Neurol 2003; 184: 162–168.

    Article  CAS  PubMed  Google Scholar 

  43. Boyle DL, Moore J, Yang L, Sorkin LS, Firestein GS . Spinal adenosine receptor activation inhibits inflammation and joint destruction in rat adjuvant-induced arthritis. Arthritis Rheum 2002; 46: 3076–3082.

    Article  CAS  PubMed  Google Scholar 

  44. Joris J, Costello A, Dubner R, Hargreaves KM . Opiates suppress carrageenan-induced oedema and hyperthermia at doses that inhibit hyperalgesia. Pain 1990; 43: 95–103.

    Article  CAS  PubMed  Google Scholar 

  45. Hong Y, Abbott FV . Peripheral opioid modulation of pain and inflammation in the formalin test. Eur J Pharmacol 1995; 277: 21–28.

    Article  CAS  PubMed  Google Scholar 

  46. Binder W, Machelska H, Mousa S, Schmitt T, Rivière PJM, Junien JL et al. Analgesic and antiinflammatory effects of two novel κ-opioid peptides. Anesthesiology 2001; 94: 1034–1044.

    Article  CAS  PubMed  Google Scholar 

  47. Green PG, Levine JD . ä- and κ-opioid receptor agonists inhibit plasma extravasation induced by bradykinin in the knee joint of the rat. Neuroscience 1992; 49: 129–133.

    Article  CAS  PubMed  Google Scholar 

  48. Barber A . μ and κ-opioid receptor agonists produce peripheral inhibition of neurogenic plasma extravasation in rat skin. Eur J Pharmacol 1993; 236: 113–120.

    Article  CAS  PubMed  Google Scholar 

  49. Taylor BK, Peterson MA, Roderick RE, Tate J, Green PJ, Levine JO et al. Opioid inhibition of formalin-induced changes in plasma extravasation and local blood flow in rats. Pain 2000; 84: 263–270.

    Article  CAS  PubMed  Google Scholar 

  50. Zhou L, Zhang Q, Stein C, Schafer M . Contribution of opioid receptors on primary afferent versus sympathetic neurons to peripheral opioid analgesia. J Pharmacol Exp Ther 1998; 286: 1000–1006.

    CAS  PubMed  Google Scholar 

  51. Romero A, Planas E, Poveda R, Sanchez S, Pol O, Puig MM . Anti-exudative effects of opioid receptor agonists in a rat model of carrageenan-induced acute inflammation of the paw. Eur J Pharm 2005; 511: 207–217.

    Article  CAS  Google Scholar 

  52. Lei YH, Rogers DF . Effects and interactions of opioids on plasma exudation induced by cigarette evaluated by the intraperitoneal bradykinin-evoked pain method in man. Clin Pharmacol Ther 1999; 8: 521–542.

    Google Scholar 

  53. Wilson SP, Yeomans DC, Bender MA, Lu Y, Goins WF, Glorioso JC . Antihyperalgesic effects of infection with a preproenkephalin-encoding herpes virus. Proc Natl Acad Sci USA 1999; 96: 3211–3216.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Yeomans DC, Lu Y, Laurito CE, Peters MC, Vota-Vellis G, Wilson SP et al. Recombinant herpes vector-mediated analgesia in a primate model of hyperalgesia. Mol Ther 2006; 13: 589–597.

    Article  CAS  PubMed  Google Scholar 

  55. Mudge AW, Leeman SE, Fischbach GD . Enkephalin inhibits release of substance P from sensory neurons in culture and decreases action potential duration. Proc Natl Acad Sci USA 1979; 76: 526–530.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Tsunoo A, Yoshii M, Narahashi T . Block of calcium channels by enkephalin and somatostatin in neuroblastoma-glioma hybrid NG108-15 cells. Proc Natl Acad Sci USA 1986; 83: 9832–9836.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Goins WF, Yoshimura N, Phelan MW, Yokoyama T, Fraser MO, Ozawa H et al. Herpes simplex virus mediated nerve growth factor expression in bladder and afferent neurons: potential treatment for diabetic bladder dysfunction. J Urol 2001; 165: 1748–1754.

    Article  CAS  PubMed  Google Scholar 

  58. Minter RM, Ferry MA, Murday ME, Tannahill CL, Bahjat FR, Oberholzer C et al. Adenoviral delivery of human and viral IL-10 in murine sepsis. J Immunol 2001; 167: 1053–1059.

    Article  CAS  PubMed  Google Scholar 

  59. Goss JR, Goins WF, Lacomis D, Mata M, Glorioso JC, Fink DJ . Herpes simplex-mediated gene transfer of nerve growth factor protects against peripheral neuropathy in streptozotocin-induced diabetes in the mouse. Diabetes 2002; 51: 2227–2232.

    Article  CAS  PubMed  Google Scholar 

  60. Stein C, Pfluger M, Yassouridis A, Hoelzl J, Lehrberger K, Welte C et al. No tolerance to peripheral morphine analgesia in presence of opioid expression in inflamed synovia. J Clin Invest 1996; 98: 793–799.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  61. Toyoizumi T, Mick R, Abbas AE, Kang EH, Kaiser LR, Molnar-Kimber KL . Combined therapy with chemotherapeutic agents and herpes simplex virus type 1 ICP34.5 mutant (HSV-1716) in human non-small cell lung cancer. Hum Gene Ther 1999; 10: 3013–3029.

    Article  CAS  PubMed  Google Scholar 

  62. Thomas DL, Fraser NW . HSV-1 therapy of primary tumors reduces the number of metastases in an immune-competent model of metastatic breast cancer. Mol Ther 2003; 8: 543–551.

    Article  CAS  PubMed  Google Scholar 

  63. Papanastassiou V, Rampling R, Fraser M, Petty R, Hadley D, Nicoll J et al. The potential for efficacy of the modified (ICP 34.5(−)) herpes simplex virus HSV1716 following intratumoural injection into human malignant glioma: a proof of principle study. Gene Therapy 2002; 9: 398–406.

    Article  CAS  PubMed  Google Scholar 

  64. Markert JM, Liechty PG, Wang W, Gaston S, Braz E, Karrasch M et al. Phase Ib trial of mutant herpes simplex virus G207 inoculated pre- and post-tumor resection for recurrent GBM. Mol Ther 2009; 17: 199–207.

    Article  CAS  PubMed  Google Scholar 

  65. Antonijevic I, Mousa SA, Schafer M, Stein C . Perineurial defect and peripheral opioid analgesia in inflammation. J Neurosci 1995; 15: 165–172.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Lamigeon C, Bellier JP, Sacchettoni S, Rujano M, Jacquemont B . Enhanced neuronal protection from oxidative stress by coculture with glutamic acid decarboxylase-expressing astrocytes. J Neurochem 2001; 77: 598–606.

    Article  CAS  PubMed  Google Scholar 

  67. Schafer M, Zhou L, Stein C . Cholecystokinin inhibits peripheral opioid analgesia in inflamed tissue. Neuroscience 1998; 82: 603–611.

    Article  CAS  PubMed  Google Scholar 

  68. Stein C . The control of pain in peripheral tissue by opioids. N Engl J Med 1995; 332: 1685–1690.

    Article  CAS  PubMed  Google Scholar 

  69. Walker JS . Effect of opioids immune mechanisms of pain and analgesia. In: Machelska H, Stein C (eds), Immune Mechanisms of Pain and Analgesia. Kluwer Academic/Plenum Publishers: Georgetown, TX, 2003.

    Google Scholar 

  70. Collin E, Mauborgne A, Bourgoin S, Beneliel JJ, Hamon M, Cesselin F . Morphine reduces the release of met-enkephalin-like material from rat spinal cord in vivo by acting at delta opioids receptors. Neuropeptides 1994; 27: 75–83.

    Article  CAS  PubMed  Google Scholar 

  71. Way EL, Loh HH, Shen F-H . Simultaneous quantitative assessment of morphine tolerance and dependence. J Pharm Exp Ther 1969; 167: 1–8.

    CAS  Google Scholar 

  72. Gu G, Kondo I, Hua XY, Yaksh TL . Resting and evoked substance P release during chronic intrathecal morphine infusions: parallels with tolerance and dependence. J Pharm Exp Ther 2005; 314: 1362–1369.

    Article  CAS  Google Scholar 

  73. Bilsky EJ, Inturrisi CE, Sadee W, Rhuby VJ, Porreca F . Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective μ or δ opioid agonists in mice. Pain 1996; 68: 229–237.

    Article  CAS  PubMed  Google Scholar 

  74. Trang T, Sutak R, Quirion R, Jhamandas K . Role of spinal neuropeptides and prostaglandins in opioids physical dependence. Br J Pharm 2007; 136: 37–48.

    Article  Google Scholar 

  75. Hao S, Hu J, Fink DJ . Transgene-mediated enkephalin expression attenuates signs of naloxone-precipitated morphine withdrawal in rats with neuropathic pain. Behav Brain Res 2009; 197: 84–89.

    Article  CAS  PubMed  Google Scholar 

  76. Trujillo KA, Bronstein DM, Akil H . Regulation of opioids peptides by self-administered drugs. In: RP Hammer (ed). Neurobiology of Opioids. CRC Press: Boca Raton, FL, 1993, pp 223–256.

    Google Scholar 

  77. Gudehithlu KP, Tejwani Ga, Bhargava HN . β-Endorphin and met-enkephalin levels in discrete brain regions, spinal cord, pituitary gland and plasma of morphine tolerant-dependent and abstinent rats. Brain Res 1991; 553: 284–290.

    Article  CAS  PubMed  Google Scholar 

  78. Uhl GR, Ryan JP, Schwartz JP . Morphine alters preproenkephalin gene expression. Brain Res 1988; 459: 391–397.

    Article  CAS  PubMed  Google Scholar 

  79. Chauvin C, Suh M, Remy C, Benabid AL . Failure to detect viral genomic sequences of three viruses (herpes simplex, simian virus 40 and adenovirus) in human and rat brain tumors. Ital J Neurol Sci 1990; 11: 347–357.

    Article  CAS  PubMed  Google Scholar 

  80. Todo T . Oncolytic virus therapy using genetically engineered herpes simplex viruses. Hum Cell 2002; 15: 151–159.

    Article  PubMed  Google Scholar 

  81. Shah AC, Benos D, Gillespie GY, Markert JM . Oncolytic viruses: clinical applications as vectors for the treatment of malignant gliomas. J Neurooncol 2003; 65: 203–226.

    Article  PubMed  Google Scholar 

  82. Yu Z, Eisenberg DP, Singh B, Shah JP, Fong Y, Wong RJ . Treatment of aggressive thyroid cancer with an oncolytic herpes virus. Int J Cancer 2004; 112: 525–532.

    Article  CAS  PubMed  Google Scholar 

  83. Satoh T, Irie A, Egawa S, Baba S . In situ gene therapy for prostate cancer. Curr Gene Ther 2005; 5: 111–119. Review.

    Article  CAS  PubMed  Google Scholar 

  84. Sawai H, Yamamoto M, Okada Y, Sato M, Akamo Y, Takeyama H et al. Alteration of integrins by interleukin-1alpha in human pancreatic cancer cells. Pancreas 2001; 23: 399–405.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Physiology, Chandler Medical Center, University of Kentucky, Lexington, KY, USA

    K N Westlund

Authors
  1. K N Westlund
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K N Westlund.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Westlund, K. Gene therapy for pancreatitis pain. Gene Ther 16, 483–492 (2009). https://doi.org/10.1038/gt.2009.27

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/gt.2009.27

Keywords

This article is cited by

Search

Advanced search

Quick links